Jean-Pierre Sommadossi's Net Worth
$25.8 Million
Who is Jean-Pierre Sommadossi?
Jean-Pierre Sommadossi has an estimated net worth of $25.8 Million. This is based on reported shares across multiple companies, which include Atea Pharmaceuticals, Inc., Kezar Life Sciences, Inc., ABG Acquisition Corp. I, and IDENIX PHARMACEUTICALS INC.
SEC CIK
Jean-Pierre Sommadossi's CIK is 0001296995
Past Insider Trading and Trends
2004 was Jean-Pierre Sommadossi's most active year for acquiring shares with 3 total transactions. Jean-Pierre Sommadossi's most active month to acquire stocks was the month of December. 2018 was Jean-Pierre Sommadossi's most active year for disposing of shares, totalling 2 transactions. Jean-Pierre Sommadossi's most active month to dispose stocks was the month of May. 2004 saw Jean-Pierre Sommadossi paying a total of $460,971.00 for 150,114 shares, this is the most they've acquired in one year. In 2008 Jean-Pierre Sommadossi cashed out on 110,000 shares for a total of $880,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Atea Pharmaceuticals, Inc. (AVIR) Snapshot price: $4.155
President, CEO, and Chairman
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.02% | -1.01K |
$4.00 | -$4,024.00 | 5.92M |
Jun 5
| |||
Form 4
|
∞
| 116.56K |
$3.85 | -$218,818.95 | 116.56K |
Jan 31 - Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
| +14.49% | 750K |
—
|
—
| 5.92M |
Nov 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kezar Life Sciences, Inc. (KZR) Snapshot price: $0.94
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
| +96.95% | 87.84K |
—
|
—
| 178.44K |
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ABG Acquisition Corp. I No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IDENIX PHARMACEUTICALS INC No price found
President, CEO, Chairman
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
| -5.07% | -110.00K |
$8.00 | -$880,000.00 | 2.06M |
Sep 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 29
| |||
Form 4
| +0.49% | 10K |
$9.13 | $91,300.00 | 2.06M |
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
| +2.23% | 43.75K |
$8.50 | $371,875.00 | 2.01M |
Aug 26
| |||
Form 4
| +0.33% | 6.36K |
$14.00 | $89,096.00 | 1.96M |
Feb 2 - Jul 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||